These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17696813)

  • 41. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting cancer stem cells for treatment of glioblastoma multiforme.
    Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
    Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A paired comparison between glioblastoma "stem cells" and differentiated cells.
    Schneider M; Ströbele S; Nonnenmacher L; Siegelin MD; Tepper M; Stroh S; Hasslacher S; Enzenmüller S; Strauss G; Baumann B; Karpel-Massler G; Westhoff MA; Debatin KM; Halatsch ME
    Int J Cancer; 2016 Apr; 138(7):1709-18. PubMed ID: 26519239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer stem cells: characteristics and their potential role for new therapeutic strategies.
    Bohl SR; Pircher A; Hilbe W
    Onkologie; 2011; 34(5):269-74. PubMed ID: 21577035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods for cancer stem cell detection and isolation.
    Tirino V; Desiderio V; Paino F; Papaccio G; De Rosa M
    Methods Mol Biol; 2012; 879():513-29. PubMed ID: 22610581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting.
    Munthe S; Sørensen MD; Thomassen M; Burton M; Kruse TA; Lathia JD; Poulsen FR; Kristensen BW
    J Neurooncol; 2016 Oct; 130(1):53-62. PubMed ID: 27510953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A tumorigenic subpopulation with stem cell properties in melanomas.
    Fang D; Nguyen TK; Leishear K; Finko R; Kulp AN; Hotz S; Van Belle PA; Xu X; Elder DE; Herlyn M
    Cancer Res; 2005 Oct; 65(20):9328-37. PubMed ID: 16230395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical and therapeutic implications of cancer stem cell biology.
    Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
    Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
    Fábián Á; Vereb G; Szöllősi J
    Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional role of solid tumor stem cells in disease etiology and susceptibility to therapeutic interventions.
    Ramdass B; Duggal R; Minev B; Chowdhary A; Koka P
    J Stem Cells; 2013; 8(3-4):189-231. PubMed ID: 24699025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into the cancer stem cell model of glioma tumorigenesis.
    Tang C; Chua CL; Ang BT
    Ann Acad Med Singap; 2007 May; 36(5):352-7. PubMed ID: 17549283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.